PT 625 Greg Shanken — Collaborence, Community Access & Ethical Growth in Psychedelics

Psychedelics Today

Joe Moore sits down with Greg Shanken (Colorado Psychedelic Society, Collaborence Psychedelic Business Association; founder, Higher Frequency Network) for a wide-ranging conversation about building community infrastructure, navigating censorship, and creating accessible, ethical pathways into psychedelic healing. Greg shares his personal arc from lifelong depression to ayahuasca, ketamine, and Bufo; why he launched a vetted affiliate/partner network for our space; and how Oregon–Colorado collaboration can widen access while honoring reciprocity and conservation.

Key themes
  • Collaborence: a two-day CO/OR event (online + in-person) connecting facilitators, professionals, and the public with pay-what-you-can access options.
  • Access & affordability: how to widen entry points (microdosing, breathwork, scholarships/funds) within and beyond regulated service/healing centers.
  • Censorship & platform risk: why repeated Meta account shutdowns pushed Greg to build community-based distribution outside big ad networks.
  • Personal journey: depression, SSRIs/SNRIs/ADHD meds → ayahuasca (two-night initiation), IM ketamine, and later Bufo/5-MeO-DMT.
  • Ethics & ecology: "blood toad," conservation, and the case for synthetic 5-MeO-DMT over toad-sourced material; parallels with peyote/mescaline carve-outs.
  • Leadership & culture: bringing heart-centered leadership, breathwork, and microdosing into companies; moving from transactional to mutual-aid ecosystems.
  • Regulated vs. underground: costs, insurance realities, sliding-scale models, and the role each plays in a healthy landscape.
More description

Joe Moore sits down with Greg Shanken (Colorado Psychedelic Society, Collaborence Psychedelic Business Association; founder, Higher Frequency Network) for a wide-ranging conversation about building community infrastructure, navigating censorship, and creating accessible, ethical pathways into psychedelic healing. Greg shares his personal arc from lifelong depression to ayahuasca, ketamine, and Bufo; why he launched a vetted affiliate/partner network for our space; and how Oregon–Colorado collaboration can widen access while honoring reciprocity and conservation.

Key themes
  • Collaborence: a two-day CO/OR event (online + in-person) connecting facilitators, professionals, and the public with pay-what-you-can access options.
  • Access & affordability: how to widen entry points (microdosing, breathwork, scholarships/funds) within and beyond regulated service/healing centers.
  • Censorship & platform risk: why repeated Meta account shutdowns pushed Greg to build community-based distribution outside big ad networks.
  • Personal journey: depression, SSRIs/SNRIs/ADHD meds → ayahuasca (two-night initiation), IM ketamine, and later Bufo/5-MeO-DMT.
  • Ethics & ecology: "blood toad," conservation, and the case for synthetic 5-MeO-DMT over toad-sourced material; parallels with peyote/mescaline carve-outs.
  • Leadership & culture: bringing heart-centered leadership, breathwork, and microdosing into companies; moving from transactional to mutual-aid ecosystems.
  • Regulated vs. underground: costs, insurance realities, sliding-scale models, and the role each plays in a healthy landscape.
2025-09-25 69 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.